386 related articles for article (PubMed ID: 23113703)
21. Cholestasis in neonates with red cell alloimmune hemolytic disease: incidence, risk factors and outcome.
Smits-Wintjens VE; Rath ME; Lindenburg IT; Oepkes D; van Zwet EW; Walther FJ; Lopriore E
Neonatology; 2012; 101(4):306-10. PubMed ID: 22354012
[TBL] [Abstract][Full Text] [Related]
22. The efficacy of the use of intravenous human immunoglobulin in Brazilian newborns with rhesus hemolytic disease: a randomized double-blind trial.
Santos MC; Sá C; Gomes SC; Camacho LA; Moreira ME
Transfusion; 2013 Apr; 53(4):777-82. PubMed ID: 22882285
[TBL] [Abstract][Full Text] [Related]
23. Late hyporegenerative anemia in neonates with rhesus hemolytic disease.
al-Alaiyan S; al Omran A
J Perinat Med; 1999; 27(2):112-5. PubMed ID: 10379500
[TBL] [Abstract][Full Text] [Related]
24. Management of isoimmunization in the presence of multiple maternal antibodies.
Spong CY; Porter AE; Queenan JT
Am J Obstet Gynecol; 2001 Aug; 185(2):481-4. PubMed ID: 11518913
[TBL] [Abstract][Full Text] [Related]
25. Immunoglobulins in Neonates with Rhesus Hemolytic Disease of the Fetus and Newborn: Long-Term Outcome in a Randomized Trial.
van Klink JM; van Veen SJ; Smits-Wintjens VE; Lindenburg IT; Rijken M; Oepkes D; Lopriore E
Fetal Diagn Ther; 2016; 39(3):209-13. PubMed ID: 26159803
[TBL] [Abstract][Full Text] [Related]
26. Term neonates with hemolytic disease of the newborn and necrotizing enterocolitis: a report of two cases.
Roig JC; Burchfield DJ
J Perinatol; 1994; 14(3):201-3. PubMed ID: 8064424
[TBL] [Abstract][Full Text] [Related]
27. Severe hemolytic disease of the newborn due to anti-Cw.
Byers BD; Gordon MC; Higby K
Obstet Gynecol; 2005 Nov; 106(5 Pt 2):1180-2. PubMed ID: 16260563
[TBL] [Abstract][Full Text] [Related]
28. Neonatal outcome of fetuses receiving intrauterine transfusion for severe hydrops complicated by Rhesus hemolytic disease.
Altunyurt S; Okyay E; Saatli B; Canbahishov T; Demir N; Ozkan H
Int J Gynaecol Obstet; 2012 May; 117(2):153-6. PubMed ID: 22342051
[TBL] [Abstract][Full Text] [Related]
29. Suppression of compensatory erythropoiesis in hemolytic disease of the fetus and newborn due to intrauterine transfusions.
Ree IMC; Lopriore E; Zwiers C; Böhringer S; Janssen MWM; Oepkes D; De Haas M
Am J Obstet Gynecol; 2020 Jul; 223(1):119.e1-119.e10. PubMed ID: 31978433
[TBL] [Abstract][Full Text] [Related]
30. Management and clinical consequences of red blood cell antibodies in pregnancy: A population-based cohort study.
Liu S; Ajne G; Wikman A; Lindqvist C; Reilly M; Tiblad E
Acta Obstet Gynecol Scand; 2021 Dec; 100(12):2216-2225. PubMed ID: 34476807
[TBL] [Abstract][Full Text] [Related]
31. Maternal ABO-mismatched blood for intrauterine transfusion of severe hemolytic disease of the newborn due to anti-Rh17.
Denomme GA; Ryan G; Seaward PG; Kelly EN; Fernandes BJ
Transfusion; 2004 Sep; 44(9):1357-60. PubMed ID: 15318861
[TBL] [Abstract][Full Text] [Related]
32. [Positive Coomb's test in newborns; causes and clinical consequences Summary of cases diagnosed in the Blood Bank in the years 2005 to 2012].
Kristinsdottir T; Kjartansson S; Hardardottir H; Jonsson T; Halldorsdottir AM
Laeknabladid; 2016 Jul; 102(7-8):326-31. PubMed ID: 27531851
[TBL] [Abstract][Full Text] [Related]
33. History and current standard of postnatal management in hemolytic disease of the fetus and newborn.
De Winter DP; Hulzebos C; Van 't Oever RM; De Haas M; Verweij EJ; Lopriore E
Eur J Pediatr; 2023 Feb; 182(2):489-500. PubMed ID: 36469119
[TBL] [Abstract][Full Text] [Related]
34. The role of immunoglobulins in neonatal Rhesus haemolytic disease.
Greenough A
BioDrugs; 2001; 15(8):533-41. PubMed ID: 11543694
[TBL] [Abstract][Full Text] [Related]
35. Evaluation of Rh-Hemolytic Disease in Neonates and Management with Early Intensive Phototherapy in the Neonatal Intensive Care Unit.
Tewari VV; Kumar A; Singhal A; Pillai N; Prakash A; Varghese J; Kannan V
J Trop Pediatr; 2020 Feb; 66(1):75-84. PubMed ID: 31199484
[TBL] [Abstract][Full Text] [Related]
36. Intravenous immunoglobulin in neonates with rhesus hemolytic disease: a randomized controlled trial.
Smits-Wintjens VE; Walther FJ; Rath ME; Lindenburg IT; te Pas AB; Kramer CM; Oepkes D; Brand A; Lopriore E
Pediatrics; 2011 Apr; 127(4):680-6. PubMed ID: 21422084
[TBL] [Abstract][Full Text] [Related]
37. High anti-HLA response in women exposed to intrauterine transfusions for severe alloimmune hemolytic disease is associated with mother-child HLA triplet mismatches, high anti-D titer, and new red blood cell antibody formation.
Verduin EP; Schonewille H; Brand A; Haasnoot GW; Claas FH; Lindenburg IT; Lopriore E; Oepkes D; Roelen DL; Doxiadis II
Transfusion; 2013 May; 53(5):939-47. PubMed ID: 22924899
[TBL] [Abstract][Full Text] [Related]
38. Receipt of RhD-positive whole blood for life-threatening bleeding in female children: A survey in alloimmunized mothers regarding minimum acceptable survival benefit relative to risk of maternal alloimmunization to anti-D.
Sherwood MR; Clayton S; Leeper CM; Yazer M; Moise KJ; Granger ME; Spinella PC
Transfusion; 2024 May; 64 Suppl 2():S100-S110. PubMed ID: 38563495
[TBL] [Abstract][Full Text] [Related]
39. [Haemolytic disease of the fetus and newborn/HDFN/timing in pregnant women and prophylaxis].
Kulinska R
Akush Ginekol (Sofiia); 2014; 53(2):58-63. PubMed ID: 25098112
[TBL] [Abstract][Full Text] [Related]
40. Severe intrauterine hemolysis due to anti-C(w).
Chu HP; Kanagalingam D; Chan DK
Am J Perinatol; 2007 Nov; 24(10):623-6. PubMed ID: 17972235
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
